Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva, Technion To Collaborate On Cancer, Neurobiology Research
What's 'down' with Teva? - Israel News - The Jerusalem Post
Israeli pharmaceutical giant Teva investigating bribery accusations in Romania | The Times of Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva shed 37% of Israel workforce in two years - Globes
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Teva Pharmaceutical Industries - Wikidata
Israeli Drugmaker Teva To Market Medicinal Cannabis Products - I24NEWS
Teva Israel steps into the ring to begin distributing medical cannabis - The Jerusalem Post
Israel-based Teva Pharmaceutical to lay off 14,000 workers as part of restructuring - St. Louis Jewish Light
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals - Wikipedia
U.S. Justice Department Sues Teva Over Alleged Drug Kickbacks - Israel News - Haaretz.com
Teva Pharmaceuticals | Israel National News - Arutz Sheva
Israel's Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Teva reportedly to present job cuts plan on Thursday | The Times of Israel
Can Israel find a cure for ailing drug giant Teva? – Mishpacha Magazine
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
